✦ LIBER ✦

Comparison of activated partial thromboplastin time to activated clotting time for adequacy of heparin anticoagulation just before percutaneous transluminal coronary angioplasty

✍ Scribed by Howard P. Grill; Joel E. Spero; Jerome E. Granato

Book ID: 113119004
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 258 KB
Volume: 71
Category: Article
ISSN: 0002-9149
DOI: 10.1016/0002-9149(93)90649-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of activated clotting times t

Comparison of activated clotting times to heparin management test for adequacy of heparin anticoagulation in percutaneous transluminal coronary angioplasty

✍ Helft, Gérard ;Choktron, Sylvie ;Beygui, Farzyn ;Le Feuvre, Claude ;Elalamy, Ism 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 2 views

The aim of this study was to compare the activated clotting time (ACT) obtained with the Hemochron device and the Heparin Management Test (HMT) on a new automated whole-blood coagulometer, the Thrombolytic Assessment System, in patients undergoing angioplasty. Fifty patients undergoing balloon angio

Bedside monitoring of heparin therapy: c

Bedside monitoring of heparin therapy: comparison of activated clotting time to activated partial thromboplastin time

✍ Reiner, Jonathan S. ;Coyne, Karin S. ;Lundergan, Conor F. ;Ross, Allan M. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB

Heparin anticoagulation is utilized during and after interventionai cardiac catheterization procedures to reduce the risk of acute thrombotic coronary artery occlusion. The short half-life of heparin, the importance of maintaining therapeutic anticoaguiation, and the time delay inherent in the proce

Percutaneous transluminal coronary angio

Percutaneous transluminal coronary angioplasty: Comparison of arterial vs. venous activated clotting time

✍ Pesola, Gene R. ;Johnson, Audrey ;Pesola, David A. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 514 KB

When arterial blood samples for activated clotting time (ACT) are difficult to obtain from the arterial sheath during coronary intervention, venous ACT serves as a substitute. Data are lacking on whether arterial and venous ACT are identical and whether one can serve as an effective substitute for t

Activated clotting times and activated p

Activated clotting times and activated partial thromboplastin times in patients undergoing coronary angioplasty who receive bolus doses of heparin

✍ Dougherty, Kathy G. ;Gaos, Carlos M. ;Bush, Howard S. ;Leachman, D. Richard ;Fer 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB 👁 1 views

Heparin dosing for percutaneous coronary

Heparin dosing for percutaneous coronary angioplasty: Use of body surface area to improve initial activated clotting time values

✍ Gene R. Pesola; David A. Pesola 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB

The Determinants of Activated Partial Th

The Determinants of Activated Partial Thromboplastin Time, Relation of Activated Partial Thromboplastin Time to Clinical Outcomes, and Optimal Dosing Regimens for Heparin Treated Patients with Acute Coronary Syndromes: A Review of GUSTO-IIb

✍ Michael S. Lee; Andreas U. Wali; Venu Menon; Scott D. Berkowitz; Trevor D. Thomp 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 548 KB